Drug Database
Back to search

Poland· PL-100541940

Cirrus

A pseudoephedrin, kombinationen product containing cetirizini dihydrochloridum + pseudoephedrini hydrochloridum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC R01BA52

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCirrusATCR01BA52REGISTER NO.PL-100541940PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cetirizini dihydrochloridum + pseudoephedrini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pseudoephedrin, kombinationen is registered in 10 of 19 countries.

Countries holding a registration under ATC R01BA52 (pseudoephedrin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search pseudoephedrin, kombinationen products by name

Pseudoephedrin, kombinationen · ATC R01BA52

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pseudoephedrin, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pseudoephedrin, kombinationen · price per daily dose (0.24 g)

USD · FX 28 Sept 2026

  • US United States$0.62 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Cetirizini dihydrochloridum + Pseudoephedrini hydrochloridum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
R01BA52
ATC class
Pseudoephedrin, Kombinationen
Defined daily dose
0.24 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991605674

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for pseudoephedrin, kombinationen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pseudoephedrin, kombinationen against other medicinesHow interaction checks work

Pseudoephedrin, kombinationen · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Pseudoephedrin, kombinationen in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pseudoephedrin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Cirrus, Rhinosinutab
  • Bulgaria · Зиртек-D
  • Germany · Reactine Duo
  • Estonia · Cirrus
  • Spain · Reactine, Respidina Antialérgica
  • Hungary · Zyrtec-D
  • Ireland · Zirtek Plus Decongestant
  • Italy · Reactine, Zirtec Decongestionante Antistaminico
  • Lithuania · Cirrus
  • Luxembourg · Cirrus, Rhinosinutab
  • Latvia · Cirrus
  • Malta · Cirrus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0e719b07-be08-4b77-99e1-d494123755c4
GET /v1/drugs/0e719b07-be08-4b77-99e1-d494123755c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "5 mg + 120 mg",
  "packaging": "05909991605674 ¦ Rp ¦ 167794\n14 tabl.",
  "substance": "Cetirizini dihydrochloridum/5 mg + Pseudoephedrini hydrochloridum/120 mg",
  "common_name": "Cetirizini dihydrochloridum + Pseudoephedrini hydrochloridum",
  "pl_product_id": "100541940",
  "pozwolenie_nr": "270/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-07-13"
}
API referenceMCP serverPlans

See everything about pseudoephedrin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console